Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes. (Q38607553)

PubMed publication ID

28842730

4 September 2017

title

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

1 reference

1 reference

type 2 diabetes

9 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

Kaixin Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

publication date

25 August 2017

1 reference

PubMed publication ID

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

page(s)

2231-2239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

start time

25 August 2017

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin--mode of action and clinical implications for diabetes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

The role of ATM in response to metformin treatment and activation of AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Poor replication of candidate genes for major depressive disorder using genome-wide association data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

A new multipoint method for genome-wide association studies by imputation of genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

GWAMA: software for genome-wide association meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

SeqVISTA: a graphical tool for sequence feature visualization and comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

A human transporter protein that mediates the final excretion step for toxic organic cations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Molecular mechanism of action of metformin: old or new insights?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Sex hormone-binding globulin and risk of type 2 diabetes in women and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Pharmacogenetics of oral antidiabetic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

The GLUT4 glucose transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4404-2

The potential of metformin for diabetes prevention

21 January 2018

1 reference

12 December 2020

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

1 reference

12 December 2020

Information extraction from full text scientific articles: where are the keywords?

1 reference

12 December 2020

Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

1 reference

12 December 2020

10.1007/S00125-017-4404-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

Dimensions Publication ID

13 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json

13 May 2020

PubMed publication ID

28842730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6448905&resulttype=core&format=json